Connection

Co-Authors

This is a "connection" page, showing publications co-authored by SENDURAI MANI and RAMA SOUNDARARAJAN.
Connection Strength

3.413
  1. Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy. Cancers (Basel). 2019 May 24; 11(5).
    View in: PubMed
    Score: 0.712
  2. EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers. Biochim Biophys Acta Rev Cancer. 2018 12; 1870(2):229-238.
    View in: PubMed
    Score: 0.670
  3. A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome. Sci Rep. 2015 Jun 30; 5:11766.
    View in: PubMed
    Score: 0.543
  4. Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomas. Cell Rep. 2023 12 26; 42(12):113470.
    View in: PubMed
    Score: 0.243
  5. Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing. Proc Natl Acad Sci U S A. 2021 05 11; 118(19).
    View in: PubMed
    Score: 0.204
  6. CD8+ T cells inhibit metastasis and CXCL4 regulates its function. Br J Cancer. 2021 07; 125(2):176-189.
    View in: PubMed
    Score: 0.202
  7. EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures. Br J Cancer. 2021 01; 124(1):259-269.
    View in: PubMed
    Score: 0.198
  8. Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers. Front Oncol. 2018; 8:69.
    View in: PubMed
    Score: 0.164
  9. The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition. Oncotarget. 2017 Sep 12; 8(39):65548-65565.
    View in: PubMed
    Score: 0.156
  10. Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer. Cancers (Basel). 2021 Oct 28; 13(21).
    View in: PubMed
    Score: 0.053
  11. A proteogenomic portrait of lung squamous cell carcinoma. Cell. 2021 08 05; 184(16):4348-4371.e40.
    View in: PubMed
    Score: 0.052
  12. Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge. NPJ Breast Cancer. 2021 May 28; 7(1):66.
    View in: PubMed
    Score: 0.051
  13. The Epithelial to Mesenchymal Transition Promotes Glutamine Independence by Suppressing GLS2 Expression. Cancers (Basel). 2019 Oct 22; 11(10).
    View in: PubMed
    Score: 0.046
  14. GSK3? regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer. Breast Cancer Res. 2019 03 07; 21(1):37.
    View in: PubMed
    Score: 0.044
  15. A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers. Proc Natl Acad Sci U S A. 2017 11 14; 114(46):E9903-E9912.
    View in: PubMed
    Score: 0.040
  16. FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition. Sci Rep. 2016 Apr 11; 6:23070.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.